Bone Marrow Transplant Market By Type (Autologous Transplant, Allogeneic Transplant, and Others), By Treatment Type (Leukemia, Lymphoma, Myeloma, Myelodysplastic Syndrome, Myeloproliferative Disorders, Aplastic Anemia, Solid Tumors, Sickle Cell Anemia, Thalassemia, and Others), By End User (Hospitals, Multi-specialty Clinics, and Ambulatory Surgical Centers), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Bone Marrow Transplant Market size was valued at USD 10.28 billion in 2023 and is poised to grow at a CAGR of 5.2% over 2024-2030. The global bone marrow transplant market refers to the medical industry involved in the transplantation of healthy bone marrow cells to replace damaged or diseased bone marrow. This procedure is primarily used in the treatment of various blood disorders, cancers, and immune system disorders. A major driver of the bone marrow transplant market is the increasing prevalence of blood-related diseases, such as leukemia and lymphoma, which require transplantation as a potentially curative treatment option. Additionally, advancements in transplantation techniques, improved compatibility testing, and the availability of better post-transplant care have contributed to the market's growth. However, the bone marrow transplant market also faces certain challenges. The high cost associated with the procedure, including pre-transplant testing, transplantation itself, and post-transplant care, poses a significant challenge for patients and healthcare systems. Furthermore, the availability of suitable donors and the risk of graft-versus-host disease (GVHD) are significant hurdles in the successful implementation of bone marrow transplants. The global bone marrow transplant market is driven by the increasing prevalence of blood disorders, advancements in transplantation techniques, and improved post-transplant care. Nevertheless, challenges such as high costs, donor availability, and the risk of GVHD need to be addressed for the market's continued growth.

Bone Marrow Transplant Market Key Developments:
  • In January 2022, Celgene and Bluebird Bio announced a collaboration to develop and commercialize CAR T-cell therapies for blood cancers. The collaboration will combine Celgene's expertise in hematology and oncology with Bluebird Bio's expertise in CAR T-cell technology.
  • In February 2022, Gilead Sciences and Kite Pharma announced a collaboration to develop and commercialize CAR T-cell therapies for blood cancers. The collaboration will combine Gilead Sciences' global reach and commercial expertise with Kite Pharma's expertise in CAR T-cell technology.

Bone Marrow Transplant Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.2%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Bone Marrow Transplant Market Dynamics

Burgeoning the prevalence of blood-related diseases, such as leukemia and lymphoma is expected to boost the demand for bone marrow transplant market. These diseases require intensive treatment, and in many cases, bone marrow transplantation offers a potentially curative option. The rising incidence of these disorders globally has created a growing demand for bone marrow transplants. Furthermore, advancements in medical research and technology have improved the success rates and outcomes of these procedures, making them an attractive treatment choice. As a result, the increasing prevalence of blood-related diseases are propelling the growth of the bone marrow transplant market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Bone Marrow Transplant Market Segmentation

By Type
  • Autologous Transplant
  • Allogenic Transplant
  • Others
By Treatment Type
  • Leukemia
  • Lymphoma
  • Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Disorders
  • Aplastic Anemia
  • Solid Tumors
  • Sickle cell Anemia
  • Thalassemia
  • Others
By End User
  • Hospitals
  • Multi-specialty Clinics
  • Ambulatory Surgical Centers
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The global bone marrow transplant market size was valued at USD 10.28 billion in 2023

The growth of the global bone marrow transplant market is driven by factors such as the increasing prevalence of blood disorders and cancers, advancements in transplantation techniques, improved post-transplant care, and a growing focus on personalized medicine and targeted therapies.

North America and Europe have traditionally been the dominant markets for bone marrow transplants. However, the Asia Pacific region is expected to witness significant growth in the coming years due to increasing healthcare infrastructure, rising prevalence of blood disorders, and improving access to transplantation facilities.

1.Executive Summary
2.Global Bone Marrow Transplant Market Introduction 
2.1.Global Bone Marrow Transplant Market  - Taxonomy
2.2.Global Bone Marrow Transplant Market  - Definitions
2.2.1.Type 
2.2.2.Treatment Type
2.2.3.End User
2.2.4.Region
3.Global Bone Marrow Transplant Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Bone Marrow Transplant Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Bone Marrow Transplant Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Autologous Transplant
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Allogenic Transplant
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Bone Marrow Transplant Market  By Treatment Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Leukemia
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Lymphoma
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Myeloma
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Myelodysplastic Syndrome
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Myeloproliferative Disorders
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Aplastic Anemia
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Solid Tumors
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Sickle cell Anemia
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
6.9. Thalassemia
6.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.9.3. Market Opportunity Analysis 
6.10. Others
6.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.10.3. Market Opportunity Analysis 
7.Global Bone Marrow Transplant Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Multi-specialty Clinics
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Bone Marrow Transplant Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Bone Marrow Transplant Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Autologous Transplant
9.1.2.Allogenic Transplant
9.1.3.Others
9.2.  Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Leukemia
9.2.2.Lymphoma
9.2.3.Myeloma
9.2.4.Myelodysplastic Syndrome
9.2.5.Myeloproliferative Disorders
9.2.6.Aplastic Anemia
9.2.7.Solid Tumors
9.2.8.Sickle cell Anemia
9.2.9.Thalassemia
9.2.10.Others
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Multi-specialty Clinics
9.3.3.Ambulatory Surgical Centers
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Bone Marrow Transplant Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Autologous Transplant
10.1.2.Allogenic Transplant
10.1.3.Others
10.2.  Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Leukemia
10.2.2.Lymphoma
10.2.3.Myeloma
10.2.4.Myelodysplastic Syndrome
10.2.5.Myeloproliferative Disorders
10.2.6.Aplastic Anemia
10.2.7.Solid Tumors
10.2.8.Sickle cell Anemia
10.2.9.Thalassemia
10.2.10.Others
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Multi-specialty Clinics
10.3.3.Ambulatory Surgical Centers
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Bone Marrow Transplant Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Autologous Transplant
11.1.2.Allogenic Transplant
11.1.3.Others
11.2.  Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Leukemia
11.2.2.Lymphoma
11.2.3.Myeloma
11.2.4.Myelodysplastic Syndrome
11.2.5.Myeloproliferative Disorders
11.2.6.Aplastic Anemia
11.2.7.Solid Tumors
11.2.8.Sickle cell Anemia
11.2.9.Thalassemia
11.2.10.Others
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Multi-specialty Clinics
11.3.3.Ambulatory Surgical Centers
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Bone Marrow Transplant Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Autologous Transplant
12.1.2.Allogenic Transplant
12.1.3.Others
12.2.  Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Leukemia
12.2.2.Lymphoma
12.2.3.Myeloma
12.2.4.Myelodysplastic Syndrome
12.2.5.Myeloproliferative Disorders
12.2.6.Aplastic Anemia
12.2.7.Solid Tumors
12.2.8.Sickle cell Anemia
12.2.9.Thalassemia
12.2.10.Others
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Multi-specialty Clinics
12.3.3.Ambulatory Surgical Centers
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Bone Marrow Transplant Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Autologous Transplant
13.1.2.Allogenic Transplant
13.1.3.Others
13.2.  Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Leukemia
13.2.2.Lymphoma
13.2.3.Myeloma
13.2.4.Myelodysplastic Syndrome
13.2.5.Myeloproliferative Disorders
13.2.6.Aplastic Anemia
13.2.7.Solid Tumors
13.2.8.Sickle cell Anemia
13.2.9.Thalassemia
13.2.10.Others
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Multi-specialty Clinics
13.3.3.Ambulatory Surgical Centers
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Lonza
14.2.2.Beike Biotechnology Co., Ltd.
14.2.3.Mesoblast Ltd
14.2.4.AllCells
14.2.5.STEMCELL Technologies Inc.
14.2.6.Charles River Laboratories
14.2.7.FUJIFILM Cellular Dynamics, Inc.
14.2.8.CORESTEM, Inc.
14.2.9.Gamida Cell
14.2.10.Merck KgaA
14.2.11.Sanofi
15. Research Methodology 
16. Appendix and Abbreviations 
  • Lonza
  • Beike Biotechnology Co., Ltd.
  • Mesoblast Ltd
  • AllCells
  • STEMCELL Technologies Inc.
  • Charles River Laboratories
  • FUJIFILM Cellular Dynamics, Inc.
  • CORESTEM, Inc.
  • Gamida Cell
  • Merck KgaA
  • Sanofi
  • Lifeline Cell Technology
  • PromoCell GmbH.

Adjacent Markets